Opportunity Information: Apply for RFA HL 13 011
Apply for RFA HL 13 011
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Limited Competition NHLBI Research Centers at Minority Serving Institutions Phase II (P50)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.233 National Center on Sleep Disorders Research 93.837 Cardiovascular Diseases Research 93.838 Lung Diseases Research 93.839 Blood Diseases and Resources Research.
- This funding opportunity was created on Apr 6, 2012 and posted on Apr 4, 2012.
- Applicants must submit their applications by Jun 13, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $7,000,000.00 to eligible and selected applicants.
- Eligible applicants include: Private institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Public and State controlled institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Limited Competition NHLBI Research Centers at Minority Serving Institutions Phase II (P50) funding opportunity (RFA-HL-13-011) is a National Institutes of Health grant announcement from the National Heart, Lung, and Blood Institute (NHLBI) designed specifically for a small, defined pool of applicants. It is not an open competition; only investigators and institutions that previously received Phase I funding under the NHLBI Research Centers at Minority Serving Institutions (MSI) program are eligible to apply. In practical terms, this means the program is structured as a continuation pathway: Phase I awardees that demonstrated strong progress during the early, capacity-building stage can compete for Phase II center support to fully launch and operate a more mature, multi-component research center.
The central purpose of the opportunity is to establish and sustain research centers at Minority Serving Institutions in order to expand and strengthen institutional research capabilities and resources in biomedical and behavioral research relevant to heart, lung, and blood diseases and related disorders. Beyond building infrastructure, the broader long-term aim is to grow and diversify the biomedical and behavioral research workforce and enterprise. The FOA emphasizes that these centers should enhance research competitiveness, support high-quality science in NHLBI mission areas, and create an environment where investigators and trainees from underrepresented backgrounds can be recruited, retained, and supported through meaningful research opportunities and mentorship.
The program is explicitly organized into two phases. Phase I lasts about two years and focuses on foundational development, including recruitment and retention activities and establishment of an External Advisory Board. Phase II, which this FOA supports, lasts about five years and is centered on developing and carrying out the research program and research operations. Importantly, Phase II is described as dependent on the success of Phase I, reinforcing that applicants must show they used Phase I effectively to put the building blocks in place for a functioning center with sound oversight, credible planning, and readiness to execute a sustained research agenda.
This announcement uses the NIH center grant mechanism (P50), which typically supports integrated, multi-project center structures rather than a single standalone research project. While the detailed internal requirements are contained in the full FOA text, the overall intent is to fund coordinated center activities that combine scientific projects with the operational and developmental elements needed to run a productive research center. In this context, Phase II support is meant to move beyond initial planning and staffing efforts into active research implementation, stronger administrative and research operations, and an established trajectory for continued growth in NHLBI-relevant science at the institution.
Eligibility is limited to specific types of U.S.-based institutions of higher education and designated Minority Serving Institutions, consistent with the program goals. Eligible applicants include public or state-controlled institutions of higher education and private institutions of higher education, as well as MSIs such as Historically Black Colleges and Universities (HBCUs), Hispanic-Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and other eligible MSI categories as clarified in the FOA. Foreign institutions are not eligible, and foreign components of U.S. organizations are not allowed, aligning with the announcement language that non-U.S. entities and foreign components (as defined by NIH policy) may not participate as applicants under this specific opportunity.
From an administrative standpoint, the opportunity is categorized as a discretionary grant program in the health funding area, with relevant CFDA program areas listed under NHLBI-related research domains (including cardiovascular, lung, blood, and sleep disorders research). The announcement indicates there is no cost sharing or matching requirement, which means applicants are not required to provide non-federal funds as a condition of the award. The estimated total funding listed for the opportunity is $7,000,000, reflecting the scale of investment intended to support multiple Phase II centers and their multi-year operations under the P50 mechanism.
Key dates provided in the source information show the FOA was posted in early April 2012, with an original closing date of September 7, 2012, later reflected with a current closing date of June 13, 2012, and an archive date of July 13, 2012. As with many NIH announcements, applicants were directed to the official FOA page for full requirements and instructions, and technical assistance contacts were provided through the NIH Office of Extramural Research web support channels for access or linking problems. Overall, the opportunity is best understood as a targeted second-phase investment: it is meant to reward and extend successful Phase I MSI center-building efforts into a five-year period of active, organized, center-based research and operations that strengthen NHLBI-related research capacity while advancing workforce diversity goals.
FAQs: Limited Competition NHLBI Research Centers at Minority Serving Institutions Phase II (P50) - RFA-HL-13-011
What is this funding opportunity?
This is a National Institutes of Health (NIH) funding opportunity from the National Heart, Lung, and Blood Institute (NHLBI) titled "Limited Competition NHLBI Research Centers at Minority Serving Institutions Phase II (P50)" under FOA number RFA-HL-13-011.
Is this an open competition?
No. This is a limited competition announcement designed for a small, defined pool of applicants rather than the broader research community.
Who is eligible to apply?
Only investigators and institutions that previously received Phase I funding under the NHLBI Research Centers at Minority Serving Institutions (MSI) program are eligible to apply for this Phase II opportunity.
How does Phase I relate to Phase II?
The program is structured as a continuation pathway. Phase II is dependent on the success of Phase I, meaning Phase I awardees are expected to demonstrate strong progress during the capacity-building stage before competing for Phase II center support.
What is the purpose of the Phase II award?
The purpose is to establish and sustain research centers at Minority Serving Institutions to expand and strengthen institutional research capabilities and resources in biomedical and behavioral research relevant to heart, lung, and blood diseases and related disorders.
What is the long-term goal of the program beyond infrastructure?
Beyond building research capacity, the broader long-term aim is to grow and diversify the biomedical and behavioral research workforce and enterprise, including supporting environments where investigators and trainees from underrepresented backgrounds can be recruited, retained, and supported through research opportunities and mentorship.
What is the difference between Phase I and Phase II in this program?
Phase I lasts about two years and focuses on foundational development, including recruitment and retention activities and establishing an External Advisory Board. Phase II lasts about five years and focuses on developing and carrying out the research program and research operations as a mature center.
What grant mechanism is used for this opportunity?
This opportunity uses the NIH center grant mechanism (P50), which generally supports an integrated, multi-project center structure rather than a single standalone research project.
What kinds of activities does a P50 center typically support under this announcement?
Based on the announcement summary, the intent is to support coordinated center activities that combine scientific projects with the operational and developmental elements needed to run a productive research center, moving from early planning into active research implementation and stronger administrative and research operations.
What research areas are relevant to this FOA?
The FOA targets biomedical and behavioral research relevant to NHLBI mission areas, including heart, lung, and blood diseases and related disorders. The source information also references NHLBI-related research domains such as cardiovascular, lung, blood, and sleep disorders research.
What types of institutions can be applicants (assuming Phase I eligibility is met)?
Eligibility is limited to specific U.S.-based institutions of higher education and designated Minority Serving Institutions (MSIs). Examples listed include public or state-controlled institutions of higher education, private institutions of higher education, and MSI categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and other eligible MSI categories as clarified in the FOA.
Are foreign institutions eligible to apply?
No. Foreign institutions are not eligible to apply under this opportunity.
Are foreign components of U.S. organizations allowed?
No. Foreign components of U.S. organizations are not allowed, consistent with the announcement language that non-U.S. entities and foreign components (as defined by NIH policy) may not participate as applicants under this specific opportunity.
Is cost sharing or matching required?
No. The source information states there is no cost sharing or matching requirement, meaning applicants are not required to provide non-federal funds as a condition of the award.
How much funding is associated with this opportunity?
The estimated total funding listed is $7,000,000.
What type of grant program is this categorized as?
It is categorized as a discretionary grant program in the health funding area.
What are the key dates mentioned for this FOA?
The source information indicates the FOA was posted in early April 2012. It lists an original closing date of September 7, 2012, later reflected with a current closing date of June 13, 2012, and an archive date of July 13, 2012.
Where are the full requirements and instructions found?
Applicants were directed to the official FOA page for full requirements and instructions.
Where can applicants get help with access or linking problems?
Technical assistance contacts were provided through the NIH Office of Extramural Research web support channels for access or linking problems.
What does "Phase II center support" mean in practical terms?
In practical terms, Phase II support is meant to move beyond initial planning and staffing into active research implementation, stronger administrative and research operations, and a clear trajectory for continued growth in NHLBI-relevant science at the institution.
What oversight or governance element is specifically mentioned in Phase I?
Phase I includes establishing an External Advisory Board as part of the foundational development stage.
Why does the FOA emphasize competitiveness and workforce diversity?
The FOA emphasizes enhancing research competitiveness and supporting high-quality science in NHLBI mission areas while also promoting an environment that recruits, retains, and supports investigators and trainees from underrepresented backgrounds through research opportunities and mentorship.
Browse more opportunities from the same category: Health
Next opportunity: Electronic Learning (E Learning) Collaborative Resource Center for SV and IPV Prevention Practitioners
Previous opportunity: Lowell National Historical Park Youth Programming Spindle City Corps, 2012
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA HL 13 011
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA HL 13 011) also looked into and applied for these:
| Funding Opportunity |
|---|
| Electronic Learning (E Learning) Collaborative Resource Center for SV and IPV Prevention Practitioners Apply for CDC RFA CE12 1204 Funding Number: CDC RFA CE12 1204 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $415,000 |
| Research and Technical Assistance for Public Health Laboratories in Haiti to support post earthquake reconstruction, cholera and HIV/AIDS response Apply for RFA GH 12 002 Funding Number: RFA GH 12 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Support Services for Orphans and Vulnerable Children in Nyanza and Rift Valley Provinces, Kenya, through Local Kenyan Organizations Apply for RFA 615 12 000004 Funding Number: RFA 615 12 000004 Agency: Kenya USAID Nairobi Category: Health Funding Amount: $2,500,000 |
| Developing a Plan to Evaluate Delivery of Health Care Treatments and Services for Duchenne Muscular Dystrophy (DMD) Apply for CDC RFA DD12 1208 Funding Number: CDC RFA DD12 1208 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $150,000 |
| Surveillance of Congenital Heart Defects (CHDs) Focusing on Adolescents and Adults Apply for CDC RFA DD12 1207 Funding Number: CDC RFA DD12 1207 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $550,000 |
| Short Term Research Education Program to Increase Diversity in Health Related Research (R25) Apply for RFA HL 13 020 Funding Number: RFA HL 13 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Support for Title V/Maternal and Child Health Oral Health Services Grant Program Apply for HRSA 12 059 Funding Number: HRSA 12 059 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Limited Competition Revisions to Existing NIMH Supported Cooperative Agreement Awards (U01) Apply for PAR 12 154 Funding Number: PAR 12 154 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| FY12 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Nevada Washoe County) Apply for PA FPH 12 028 Funding Number: PA FPH 12 028 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $785,000 |
| Strengthening Surveillance for Diseases Among Newly Arrived Immigrants and Refugees Apply for CDC RFA CK12 1205 Funding Number: CDC RFA CK12 1205 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Continuing the Expansion of the Overseas Health Assessment and Management of U.S. Bound Refugees Apply for CDC RFA CK12 1207 Funding Number: CDC RFA CK12 1207 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Statewide Consumer Network Grant Apply for SM 12 002 Funding Number: SM 12 002 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $70,000 |
| Statewide Family Network Program Apply for SM 12 001 Funding Number: SM 12 001 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $70,000 |
| Integrative Omics Data Analysis for Discovery in Lung Diseases (R01) Apply for PAR 12 155 Funding Number: PAR 12 155 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Career Transition Award (K22) Apply for PAR 12 156 Funding Number: PAR 12 156 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improving Implementation of Programs for Care Treatment of HIV/AIDS in the Republic of Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1225 Funding Number: CDC RFA GH12 1225 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Research and Technical Assistance for Public Health Interventions in Haiti to support post earthquake reconstruction, cholera and HIV/AIDS Apply for RFA GH 12 001 Funding Number: RFA GH 12 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Clinical Trials Units for NIAID Networks (UM1) Apply for RFA AI 12 018 Funding Number: RFA AI 12 018 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing the Control and Elimination of Neglected Tropical Diseases Apply for CDC RFA GH12 1258 Funding Number: CDC RFA GH12 1258 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| Administrative Supplements for Collaborative Science Opportunities for Existing NIDCR Grants and Cooperative Agreements (Admin Supp) Apply for PA 12 159 Funding Number: PA 12 159 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA HL 13 011", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.